Mind Medicine (MNMD) has released an update.
Mind Medicine (MindMed) Inc., a biopharmaceutical company focused on brain health disorders, has announced a public offering of common shares and pre-funded warrants. The capital raised will be used to further research and development of their product candidates and for general corporate purposes. The offering’s completion is subject to market conditions, and the securities will be available pursuant to an effective shelf registration statement.
For further insights into MNMD stock, check out TipRanks’ Stock Analysis page.
